Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Window World of Winchester Creates Stunning Home Exteriors
    Window World of Winchester Creates Stunning Home Exteriors Business
  • Brian Binke, CEO of The Birmingham Group, Featured in Rigzone
    Brian Binke, CEO of The Birmingham Group, Featured in Rigzone World News
  • Updates on Grounding of Boeing 737 MAX 9 Aircraft
    Updates on Grounding of Boeing 737 MAX 9 Aircraft Aviation
  • War Day 142: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 142: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Deputy Secretary Sherman to Deliver Opening Remarks at the U.S.-India Alliance for Women’s Economic Empowerment Shatter Summit
    Deputy Secretary Sherman to Deliver Opening Remarks at the U.S.-India Alliance for Women’s Economic Empowerment Shatter Summit World News
  • Market Research Firm Alter Agents Expands Executive Team
    Market Research Firm Alter Agents Expands Executive Team World News
  • Introducing the Team Rethinking Zero Waste at Impact Recycling Partners
    Introducing the Team Rethinking Zero Waste at Impact Recycling Partners Business
  • Stanislav Kondrashov’s Latest Article Provides Insights on Unlocking the Future of Entrepreneurship
    Stanislav Kondrashov’s Latest Article Provides Insights on Unlocking the Future of Entrepreneurship World News
Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Posted on January 24, 2024 By NewsEditor

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Longstanding commercial medtech and diagnostic experience added to the Inmedix executive team

NORMANDY PARK, WA, USA, January 20, 2024 /EINPresswire.com/ — Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics to quantify stress biology with precision, announced today the appointment of Lucy Lu as its Chief Commercial Officer (CCO).

Lucy Lu has more than 25 years of biotech industry experience and has been a consultant to Inmedix since 2020. She most recently served as the President of North America Operations for Syncell, Inc., a biotech startup with an innovative spatial biology platform technology. From 2008 to 2014, Lucy served as SVP of Corporate and Business Development at Crescendo Bioscience. During her six years at Crescendo, she helped raise $90M in venture funding, supported the development and commercialization of a novel rheumatoid arthritis biomarker test, Vectra DA, until Crescendo’s acquisition by Myriad Genetics in 2014.

Prior to joining Crescendo, Lucy was Vice President of the US Chief Technology Office at Roche Diagnostics and was responsible for global technology scouting and assessment to support Roche Diagnostics portfolio growth. In her early career, Lucy worked on drug development at Genentech and BMS before switching to market novel life science tools at Applied Biosystems.

“I am thrilled to join Inmedix as Chief Commercial Officer, and excited to be working with a dynamic team that Dr. Holman has assembled to provide this innovative device to advance patient care,” said Ms. Lu. “By equipping healthcare professionals with this state-of-the-art tool they need, we will empower them to use our real-time data to better monitor their patients’ complex chronic conditions and devise personalized treatment plans to improve health outcomes.”

Inmedix is defining the emerging medical field of immuno-autonomics: the interface between immune function and stress biology, controlled within the brain by the autonomic nervous system (ANS). The natural stress response can beneficially impact immune function in the near term (1). However, chronic activation of the immune system by stress, mediated by the ANS, has been implicated in adversely affecting the onset and severity of autoimmune disease (2). With its CloudHRV™ diagnostic in development, Inmedix intends to provide the leading, precision tool to quantify ANS stress state to support research and clinical care.

“In 2020, Inmedix Board Director and former Crescendo Bioscience President Bernie Tobin introduced me to Lucy,” said Inmedix CEO & Co-founder Andrew J Holman, MD. “Her keen insight, thoughtful leadership and deep experience in the diagnostic field were immediately apparent. As a consultant to Inmedix since that time, her guidance to me and our growing, exceptional team has been pivotal. I could not be more pleased to have her leading our commercial efforts.”

References
1. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface
between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-
638.
2. Taylor PC, Holman A J. Rheumatoid arthritis and the emergence of immuno-autonomics.
Rheumatology (Oxford). 2019 Dec 1;58(12):2079-2080. doi: 10.1093/rheumatology/kez216. PMID:
31177267.

About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.

Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd., are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress, modulated within the brain by the autonomic nervous system (ANS). The Inmedix® CloudHRV™ diagnostic system is leading the development of heart rate variability (HRV) as a potentially informative diagnostic, therapeutic, digital health, and health economic tool. ANS profile may be the most overlooked element of personalized, precision medicine.

NOTICE:

This press release contains certain forward-looking statements, including without limitation statements regarding Inmedix’s plans for preclinical studies and product capabilities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Inmedix’s business which could significantly affect expected results, including without limitation, progress of development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and Inmedix undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release. This is not an offer to sell or an offer to purchase securities.

Andrew Holman
Inmedix Inc.
+1 2064125347
email us here

You just read:

News Provided By

January 20, 2024, 22:18 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.

Article originally published on www.einpresswire.com as Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Business

Post navigation

Previous Post: War Day 553: Hits on Russian Pskov Base and 7 more targets
Next Post: U.S. Hispanic Business Council Celebrates Chairman Roger Williams’ Steadfast Support for American Small Business

Related Posts

  • IF YOUR FINANCIAL ADVISOR RECOMMENDED ESSA PHARMA INVESTMENTS PLEASE CONTACT KT LAW
    IF YOUR FINANCIAL ADVISOR RECOMMENDED ESSA PHARMA INVESTMENTS PLEASE CONTACT KT LAW Business
  • Shawn Peterson Has Joined 1 & Fund LLC as Vice President of Sales
    Shawn Peterson Has Joined 1 & Fund LLC as Vice President of Sales Business
  • Indonesia Passenger Car Market Projected to Surpass by 2030
    Indonesia Passenger Car Market Projected to Surpass by 2030 Business
  • Lost Oak Winery Partners with Critically Acclaimed Consulting Winemaker Jean Hoefliger
    Lost Oak Winery Partners with Critically Acclaimed Consulting Winemaker Jean Hoefliger Business
  • Ransomware In-Advance Prevention Storage is Released, Not a Backup Storage
    Ransomware In-Advance Prevention Storage is Released, Not a Backup Storage Business
  • Vision Tree Service Advises Michigan Residents On Preparing Trees for Upcoming Ice Season
    Vision Tree Service Advises Michigan Residents On Preparing Trees for Upcoming Ice Season Business
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Weather Risks Shouldn’t Deter Vacation TravelAugust 24, 2025
  • Aerospace & Defense Materials Market Size $81.1 billion By 2031: Industry Growth, Drivers & Future ScopeAugust 23, 2025
  • Ecuadorian Immigrant Trains Over 100 New Insurance Agents in First Year in the U.S.August 23, 2025
  • Mary Ann Scully at Loyola University Maryland Recently Featured on Close Up RadioAugust 23, 2025
  • Project Boon Delivers Backpacks, Groceries, and Resources to Riverside Families in Back-to-School CelebrationAugust 21, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Lydia by Weiqiang Yao Wins Iron A’ Design Award in Furniture Design Category
    Lydia by Weiqiang Yao Wins Iron A’ Design Award in Furniture Design Category World News
  • Good Russians Congress 2022 09 01
    Good Russians Congress 2022 09 01 World News
  • Global Telecom Analytics Market Is Projected To Grow At A 23% Rate Through The Forecast Period
    Global Telecom Analytics Market Is Projected To Grow At A 23% Rate Through The Forecast Period Business
  • War in Ukraine, Analytics. Day 1013: A Third Path For Ukraine Arestovych, Feldman
    War in Ukraine, Analytics. Day 1013: A Third Path For Ukraine Arestovych, Feldman World News
  • SARAH ZOHAR SELECTED AS TOP LEAD INTERIOR DESIGNER AND OWNER OF THE YEAR BY IAOTP
    SARAH ZOHAR SELECTED AS TOP LEAD INTERIOR DESIGNER AND OWNER OF THE YEAR BY IAOTP World News
  • War Day 309: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 309: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Hotels in Fredericksburg Texas Staying at High Occupancy
    Hotels in Fredericksburg Texas Staying at High Occupancy Business
  • The Most Expensive reality show bids farewell to Marbella
    The Most Expensive reality show bids farewell to Marbella Tech
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .